Abeona Therapeutics (ABEO) Intangibles (2010 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Intangibles of $2.2 million for Q3 2022, up 52.58% year-over-year from $1.4 million in Q3 2021, and little changed quarter-over-quarter from $2.2 million in Q2 2022.
Abeona Therapeutics (ABEO) Intangibles (2010 - 2022) Analysis & Trends
Abeona Therapeutics' Intangibles history runs 12 years deep, the most recent figure standing at $2.2 million for Q3 2022.
- In Q3 2022, Intangibles rose 52.58% year-over-year to $2.2 million; the TTM figure through Sep 2022 stood at $2.2 million (up 52.58% YoY), while the FY2021 annual figure was $1.4 million, down 35.81% from the prior year.
- Intangibles for Q3 2022 stood at $2.2 million, roughly flat from $2.2 million in the prior quarter.
- The five-year high for Intangibles was $44.9 million in Q4 2018, with the low at $1.4 million in Q4 2021.
- The 5-year median for Intangibles is $2.6 million (2020), against an average of $13.0 million.
- The sharpest annual moves came in 2019 and 2020: Intangibles surged 1046.25% in 2019, then plunged 94.94% in 2020.
- Abeona Therapeutics' Intangibles stood at $44.9 million in 2018, then slipped by 5.02% to $42.6 million in 2019, then slumped by 94.94% to $2.2 million in 2020, then tumbled by 35.81% to $1.4 million in 2021, then surged by 55.78% to $2.2 million in 2022.
- Business Quant data shows ABEO's Intangibles at $2.2 million in Q3 2022, $2.2 million in Q2 2022, and $2.2 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Sep 30, 2020 | 2.61 Mn |
| Jun 30, 2020 | 2.61 Mn |
| Mar 31, 2020 | 2.61 Mn |
| Dec 31, 2019 | 42.61 Mn |
| Sep 30, 2019 | 42.61 Mn |
| Jun 30, 2019 | 42.61 Mn |
| Mar 31, 2019 | 41.70 Mn |
| Dec 31, 2018 | 44.86 Mn |
| Sep 30, 2018 | 3.72 Mn |
| Jun 30, 2018 | 3.80 Mn |
| Mar 31, 2018 | 3.89 Mn |
| Dec 31, 2017 | 3.98 Mn |